Business Wire

GSOA

15.12.2021 17:35:10 CET | Business Wire | Press release

Share
Satellite Operators join to shape the communications ecosystem of the future through the transformation of the EMEA Satellite Operators’ Association to the Global Satellite Operators’ Association

Chief Executives of the world’s leading satellite operators announced today in Paris on the occasion of World Satellite Business Week 2021 that ESOA, the EMEA Satellite Operators Association, is expanding to include satellite operators from all world regions and will change its name to GSOA, the Global Satellite Operators’ Association. They also announced that seven new members – Amazon, APT, ARSAT, Intersputnik, Lockheed Martin, Omnispace and Star One – had already agreed to join GSOA.

GSOA will remain the only CEO-driven satellite industry association. It will focus on a core mission of providing a unified voice and a platform for collaboration for satellite operators globally to ensure their continued success and for broadening the opportunities for policymakers and industry players to leverage satellite services to fulfil their objectives.

“The creation of GSOA reflects a strong belief in the satellite communications sector that a strong, global voice is needed to ensure that the sector is well positioned to helping create a more connected and sustainable world,” said Stephen Spengler, ESOA Chairman and CEO of Intelsat. “The fact that new members are already joining us is a demonstration of support for GSOA’s mission and the need to ensure that, together, we have a strong voice in shaping the communications ecosystem of the future.”

Leading Change

GSOA is structured to drive industry leadership in the face of three key trends: unparalleled innovation in the space sector, an insatiable demand for all types of connectivity, and a need to bring sustainability to space. In this regard, the GSOA Board has approved three broad industry goals.

GSOA is committed to:

On earth: extending connectivity globally where other networks don’t, connecting unconnected communities, schools, households, planes, ships, businesses, humanitarian agencies, peacekeepers and governments, aiming to increase the number of satellite data connections by 250% by 2030 and increase the data consumed by those connections 15 fold.

In space: preserving the space environment for future generations by designing, launching and operating satellites in a responsible way and minimising the creation of space debris.

For all: supporting the UN Sustainable Development Goals by providing access to secure, reliable and sustainable broadcast & broadband connectivity to people, schools, enterprises, organisations and devices wherever they may be, whether on the move, at work, or at play.

ESOA to GSOA

With the industry’s multi-orbit offering, the satellite sector will respond to the great majority of connectivity requirements presented by the data driven economy of tomorrow. From bridging crippling social, education, healthcare and other divides that exist due to the lack of communications infrastructure on all continents to enabling a host of 5G and IoT use cases for different vertical sectors.

Satellite operators will continue to build on the successes of ESOA which include providing the support the industry needed to push ahead with 5G standards and vital leadership on issues such as satellite spectrum and space sustainability. Through GSOA, the satellite sector will now be able to drive such global activities leveraging a global operator base.

GSOA will provide its members with the opportunity to shape the future of the satellite communications industry and the frameworks in which it operates by participating in key activities that impact the sector. Specifically, GSOA members will be able to engage in cross-sector initiatives, drive common positions, represent the industry on topics such as spectrum and 5G in events on all continents and contribute to ITU work concerning the development agenda, emergency communications and of course spectrum.

The association will continue to have a CEO-led Board, which has proved invaluable to the success of the ESOA to date, a strong Secretariat, and member-driven working groups that execute the broad agenda set by the Board.

This is an important change that will help ensure the industry is positioned well into the future ”, said Aarti Holla-Maini, the secretary general of ESOA. “We also recognize that there are other industry associations who will want to understand the implications of this change and we look forward to working with them to ensure the satellite communications sector has the strongest possible, unified global voice .”

The Global Satellite Operators Association now counts among its members: Airbus CIS, Amazon, Amos Spacecom, APT, Arabsat, Arsat, Avanti, Azercosmos, Echostar-Hughes, HellasSat, Hispasat, Inmarsat, Intelsat, Intersputnik, Lockheed Martin, Nigcomsat, Nilesat, Omnispace, OneWeb, Rascomstar, SES, SSI-Monacosat, Star One, Telenor, Telesat, Telespazio, Thuraya, Turksat, Viasat and Yahsat as well as representatives of the broader space industry including Airbus Defence and Space, Arianespace, Astroscale, Mansat, ST Engineering and Thales Alenia Space.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye